Research Published in Mayo Clinic Proceedings: Digital Health Reveals Body Composition Predicts GLP-1 Weight Loss Outcomes Research Published in Mayo Clinic Proceedings: Digital Health Reveals Body Composition Predicts GLP-1 Weight Loss Outcomes PR Newswire BOSTON, July 29, 2026 WITHINGS Withings research finds that muscle-to-fat ratio at the start of treatment is the strongest predictor of both how much weight is lost on GLP-1 therapy and whether it comes from fat or muscle
Not only do figures improve, but increased energy, diminished joint discomfort, better sleep, heightened self-image, and reduced disease risk factors are also reported benefits
Acarbose is a prescription drug that blocks carbohydrate absorption
Nutrition plays a critical role in managing type 2 diabetes and weight loss, so it is important to consider how food choices can work in combination with these medications for your overall health
Kingdom providers review medical history and risk factors before initiating treatment and continue monitoring throughout care